We therefore looked for additional rare, and moderate or high impact variants in either HBOC panel genes or candidate genes (involved in DNA repair/ cell cycle and with cancer associations in HGMD) amongst the four BRCA2 K3326* carriers. Here, BRCA2 is linked to cancer.